جست‌وجوی استاد و پژوهشگر

• Molecular Biology
• Cell Biology
• Obesity Research
• +۶ مورد دیگر

Professor Reşat Ünal is a distinguished academic at Muğla Sıtkı Koçman University, serving in the Faculty of Science, Department of Molecular Biology and Genetics. With a robust educational background including a Bachelor's degree from Hacettepe University, a Master's from Bilkent University, and a Doctorate from Karlsruhe Institute of Technology, he has established himself as a leading researcher in molecular biology and metabolic disorders. His research primarily focuses on molecular mechanisms underlying obesity, diabetes, and metabolic syndrome, with particular emphasis on adipose tissue biology, inflammation, and the effects of medicinal plant extracts. Professor Ünal has supervised multiple graduate students, including OZAN-AYDOĞDU (2020) and GÜLBEN-UYTAN (2019), guiding research on leptin receptors in spinal stenosis and plant extracts' effects on obesity markers, respectively. His extensive publication record reveals a consistent research trajectory exploring the molecular pathways of metabolic disorders, with recent work investigating plant-based therapeutic approaches for obesity and inflammation. The articles collectively demonstrate his expertise in cellular and molecular mechanisms related to metabolic health, with particular attention to adipose tissue remodeling, macrophage function, and lipid metabolism. Professor Ünal has contributed to significant research projects including 'Effects of Fish Oil on Inflammation and Metabolic Syndrome' (2009), 'Mechanisms Underlying Metabolic Syndrome in Obesity' (2009), and 'Regulation of Lipoprotein Lipase in Adipocytes' (2004), demonstrating sustained research activity in metabolic health. He serves as an editorial board member for several journals including Trakya University Journal of Natural Sciences (2020), Meta Gene (2017), and MOJ Proteomics and Bioinformatics (2014), and has performed peer review services for prestigious journals such as Archives of Physiology and Biochemistry, Biomaterials, and Turkish Journal of Biochemistry.

Iosif I. Vaismanمشاهده پروفایل

استاد

• Artificial Intelligence
• Bio-health/Health
• Biology
• +۷ مورد دیگر

Dr. Iosif I. Vaisman serves as Professor and Director of the School of Systems Biology at George Mason University, where he leads academic initiatives at the intersection of computational science and biological research. His leadership encompasses curriculum development, research oversight, and strategic direction for the school's interdisciplinary programs. His educational background includes: PhD from the Russian Academy of Sciences Dr. Vaisman's research spans Artificial Intelligence, Medical Proteomics, and Personalized Medicine with core expertise in machine learning applications for protein structure analysis. His work focuses on decoding sequence-structure-function relationships in biomolecules, developing computational mutagenesis frameworks, and creating predictive models for drug resistance and disease mechanisms. Current projects integrate deep learning with structural biology to address challenges in antimicrobial peptide design and HIV-1 pathogenesis. Analysis of his 2022-2025 publications reveals a pronounced shift toward graph neural networks and transformer models in bioinformatics, with dominant themes in protein classification (32%), antimicrobial peptide prediction (24%), and disease mechanism modeling (20%). His work consistently bridges fundamental computational geometry with translational biomedical applications, particularly in vaccine design and personalized treatment strategies.

• Genetic Epidemiology
• Cardiovascular Disease
• Hyperlipidemia
• +۳ مورد دیگر

Pia R. Kamstrup is a Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, and heads the Department of Clinical Biochemistry at Copenhagen University Hospital - Herlev and Gentofte. Her educational background includes: DMSc (Doctor Medicinae) from University of Copenhagen (awarded August 23, 2024) PhD from University of Copenhagen (awarded December 12, 2008) MD from University of Copenhagen (awarded January 17, 2002) Dr. Kamstrup's research focuses on genetic epidemiology, particularly genetically determined heritable hyperlipidemia and cardiovascular disease. She is renowned for her work on genetically determined high lipoprotein(a) and its associated morbidity and mortality. Her research utilizes large population studies including the Copenhagen General Population Study (N~150,000) and the Copenhagen Baby Heart Study (N~25,000), where she serves on the steering committees. Her work bridges clinical biochemistry with genetic epidemiology to understand cardiovascular risk factors at a population level. Her recent publications demonstrate significant contributions to understanding lipoprotein(a) in cardiovascular disease, dementia risk, and cardiac biomarker diagnostics. Her research shows consistent focus on translating genetic findings into clinical applications for cardiovascular risk assessment. Dr. Kamstrup has received lecture honoraria from the American Heart Association, Medscape, Novartis, PCSK9 Forum, and Physicians' Academy for Cardiovascular Education. She has served as a consultant for Amgen (past), Novartis (past), Lilly (present), and Silence Therapeutics (present). Her research has been supported by funding from Gangstedfonden, IMK Almene Fund, Novo Nordisk Foundation (as co-applicant), and The Danish Council for Independent Research - Medical Sciences. She is actively involved in the Lp(a) International Taskforce (ITF) initiative, contributing to global efforts in understanding and addressing lipoprotein(a)-related cardiovascular risks. She collaborates extensively with researchers across Denmark and internationally in cardiovascular genetics and epidemiology.

• Diabetes Research
• Pancreatic Beta Cell Function
• Glucagon-Like Peptide-1
• +۵ مورد دیگر

Dr. Steven Patterson is a Senior Lecturer in the School of Biological and Biomedical Sciences at Glasgow Caledonian University. His research focuses on diabetes and pancreatic beta cell function, with particular expertise in Type 2 Diabetes Mellitus, insulin secretion, and the role of microRNA in beta cell lipid metabolism. Dr. Patterson's research interests include: Glucagon-Like Peptide-1 and its analogues Type 2 Diabetes Mellitus pathogenesis and treatment Pancreatic beta cell function and survival Lipid metabolism in beta cells MicroRNA regulation in diabetes Diabetic complications, including retinopathy Dr. Patterson has published 31 research outputs with an h-index of 15 and 771 citations. His recent work (2021-2025) shows continued focus on pancreatic beta cell function, with studies on spexin analogues, microRNA, and protection against glucolipotoxicity. His research demonstrates a strong translational focus, connecting molecular mechanisms to potential clinical applications in diabetes treatment. Notable projects include: Principal Investigator on a Wellcome Trust project (2019) targeting thyroid hormone receptor beta to enhance MafA expression in pancreatic beta cells Co-investigator on research into stress hormone metabolism as an anti-fibrotic therapeutic pathway for chronic wounds (2019) Dr. Patterson actively participates in the diabetes research community, including presenting at the European Association for the Study of Diabetes Annual Meeting in 2013.

• Atherosclerosis
• Thrombosis
• CD36 Signaling
• +۵ مورد دیگر

Roy L. Silverstein, MD, is a Professor in the Department of Medicine at the Medical College of Wisconsin (MCW). He holds key affiliations with MCW's research centers, including the Cancer Center, Cardiovascular Research Center, Center for Disease Prevention Research, and Mellowes Center for Genomic Sciences and Precision Medicine, highlighting his interdisciplinary focus. His research explores mechanisms of atherosclerosis, thrombosis, and inflammation, with emphasis on: CD36 scavenger receptor signaling in macrophages and platelets Oxidative stress and redox regulation in vascular disease Lipid metabolism and metabolic inflammation Thrombospondin-mediated angiogenesis modulation Analysis of recent publications (2022-2025) reveals dominant themes: CD36's role in platelet hyperreactivity and thrombosis in metabolic disorders Ion transport (Na/K-ATPase) intersections with inflammation Macrophage metabolic reprogramming in atherosclerosis Translational studies informing clinical guidelines for thrombotic disorders While no awards are listed in the source text, his extensive publication record in high-impact journals underscores significant scholarly contributions. He mentors through research collaborations but no specific advisees are named.

• Lipoprotein metabolism
• HDL (High-Density Lipoprotein) research
• Atherosclerosis
• +۷ مورد دیگر

Mary Sorci Thomas, PhD is a Professor with Tenure in the Department of Medicine, Division of Endocrinology at the Medical College of Wisconsin and in the Department of Pathology Section on Lipid Sciences at Wake Forest University School of Medicine. She serves as Associate Director of the Cardiovascular Center and Associate Program Director of the CVC T32 Training Program at MCW. Dr. Sorci Thomas is an internationally recognized expert in lipoprotein metabolism and HDL research with over 30 years of continuous NIH funding. Dr. Sorci Thomas's research program focuses on the structural and functional properties of apolipoprotein A-I and HDL, with particular emphasis on how these relate to cholesterol transport, inflammation, and atherosclerosis. Her work has provided fundamental insights into the mechanisms of HDL biogenesis, the role of specific apolipoprotein domains in LCAT activation, and the relationship between HDL function and immune regulation. Her laboratory employs a multidisciplinary approach combining protein chemistry, molecular biology, cell culture, and animal models to investigate these processes. Analysis of Dr. Sorci Thomas's recent publications reveals a continued focus on HDL structure-function relationships, with increasing attention to the connections between lipid metabolism, inflammation, and vascular biology. Her work spans basic mechanistic studies of apolipoprotein structure to translational investigations of HDL function in disease processes, demonstrating a consistent trajectory of high-impact research in lipoprotein biology. Established Investigator, American Heart Association (1994-1999) Women's Mentoring Award, American Heart Association (2002) Special Recognition Award, Arteriosclerosis, Thrombosis and Vascular Biology Council (2002) Chair, Gordon Conference on Lipoprotein Metabolism (2006) Chair, Kern Aspen Lipid Meeting (2010-Present) Co-Chair, Atherosclerosis, Thrombosis and Vascular Biology Council of AHA (2016-2022) Dr. Sorci Thomas has mentored numerous students, postdocs, and junior faculty throughout her career. As Associate Program Director of the CVC T32 Training Program at MCW, she continues to play an active role in training the next generation of cardiovascular researchers. Her mentorship extends beyond her own laboratory through her leadership roles in national organizations and scientific review panels.

Marite Cardenasمشاهده پروفایل

استاد

• Physical Chemistry
• Colloid and Surface Chemistry
• Biological Interfaces
• +۲ مورد دیگر

Marite Cardenas is a Professor at Malmö University's Faculty of Health and Society, Department of Biomedical Science. An expert in physical chemistry, she researches structure-function relationships in biological interfaces and colloids. Her work bridges biomedical science and nanotechnology with applications in biomaterials and drug delivery. Research interests include: Colloid and surface chemistry of biological systems Nanomaterial design inspired by biological structures Lipid membrane dynamics and stability Biophysical characterization techniques She leads projects like 'Lipoprotein structure and disease development' and is affiliated with the Biofilms Research Center for Biointerfaces. Recent publications focus on peptide coacervates, inhalable carriers, and cellulose-based nanomaterials, reflecting strong activity in soft matter biophysics.

Jason McDermottمشاهده پروفایل

دانشیار

• Systems biology
• Network inference
• Data integration
• +۱۰ مورد دیگر

Jason McDermott is a senior research scientist and Team Lead for Systems Biology at Pacific Northwest National Laboratory (PNNL), with an Affiliate Associate Professor appointment in the Department of Molecular Microbiology and Immunology at Oregon Health & Science University (OHSU). His work bridges computational and experimental biology, focusing on data integration, network analysis, and systems-level understanding of biological processes. McDermott earned his BA in Biology from Reed College in 1993, PhD in Structural Virology from OHSU in 2000, and completed post-doctoral training in Bioinformatics at the University of Washington in 2006. His research spans cancer biology, host-pathogen interactions, microbiome science, and computational prediction of protein functions. His work integrates high-throughput omics data to develop systems biology models, with particular emphasis on biomarker discovery, network inference, and pathway analysis. Recent publications demonstrate his leadership in applying multi-omics approaches to understand viral infections, soil microbial communities, cancer mechanisms, and metabolic diseases. His research portfolio shows consistent focus on developing computational methods for biological data integration and analysis, with applications across diverse domains from infectious disease to cancer biology and environmental microbiology. 1997 Sears Fellowship Award (OHSU) 1998 Tartar Fellowship Award (OHSU) 2008 Analytics Challenge Winner (Supercomputing 2008) McDermott actively collaborates with experimental biologists, statisticians, and mass spectrometrists to develop and apply computational methods. He has made significant contributions to the Clinical Proteomic Tumor Analysis Consortium (CPTAC), particularly in ovarian cancer research, where he serves as chair of both the biology working group and data analysis working group. His work often involves interdisciplinary teams focused on translating computational insights into biological understanding.

Brian Cummingsمشاهده پروفایل

استاد

• Molecular Mechanisms of Cell Death
• Lipid Biochemistry
• Toxicology
• +۴ مورد دیگر

Brian Cummings is Dean and Professor of Pharmaceutical Sciences at Wayne State University's Eugene Applebaum College of Pharmacy and Health Sciences. He holds a PhD in Pharmacology from Wayne State (1999) and a BS in Biochemistry/Toxicology from Eastern Michigan University (1994), with postdoctoral training at the Medical University of South Carolina and University of Arkansas. His research explores molecular mechanisms of cell death, focusing on lipid biochemistry, nanoparticle toxicology, and targeted cancer therapeutics. Key areas include secretory phospholipase A2-responsive drug delivery, glypican regulation in tumors, and environmental toxicant impacts on lipidomics. His work integrates pharmacology, nanotechnology, and epigenetics to address prostate cancer metastasis and nephrotoxicity. Recent publications emphasize nanomedicine safety, lipidomic alterations in disease, and kinase inhibition strategies. Trends show consistent focus on: Liposome-based targeted cancer therapy Toxicokinetics of environmental pollutants Epigenetic regulation in renal toxicity PAK-1 signaling in metastasis Awards & Honors: 2016 ASPET Outstanding Achievement in Toxicology 2012 UGA Meritorious Research Award 2009 UGA Excellence in Mentoring 2008 Teacher of the Year (UGA Pharmacy) 2005 Georgia Cancer Coalition Scholar He directs multiple grants including a DoD-funded project on liposomal delivery for prostate cancer ($1.03M total). Current clinical work involves lipidomic profiling in cancer patients at the University of Iowa. Editorial roles include Toxicological Sciences and Biochemical Pharmacology .

Lise Arlethمشاهده پروفایل

استاد

• Small-angle Scattering
• Biophysics
• Membrane Protein Research
• +۶ مورد دیگر

Lise Arleth serves as Professor in Experimental Biophysics and Associate Dean for Research at the Faculty of Science, University of Copenhagen, where she leads the X-ray and Neutron Science Group at the Niels Bohr Institute. Her academic career spans over two decades with progressive appointments from Assistant Professor to full Professor, including significant leadership roles such as Head of the PhD School at KU-Life and Head of Studies for Physics at the Niels Bohr Institute. Her educational background includes an M.Sc. in Physics and Mathematics from Roskilde University (1995) with international research stays in Paris, followed by a Ph.D. in Biophysics from Risø National Laboratory and the Royal Veterinary and Agricultural University (2002). Her postdoctoral training included positions at Los Alamos National Laboratory and multiple international research institutions. Arleth's research specializes in solution small-angle scattering techniques (SAXS and SANS) for investigating self-assembling and colloidal systems with biological, biotechnological, and pharmaceutical relevance. Her work focuses on lipid-protein co-structures including nanodiscs and high-density lipoproteins for membrane protein studies. She maintains strong engagement with major international facilities including the European Spallation Source (ESS) and Max-IV synchrotron, where she serves on multiple scientific advisory committees and the Max-IV Board. Her publication record includes 81 peer-reviewed papers with approximately 2,500 citations and an H-index of 27. Her research group maintains extensive national and international collaborations across academia and industry, particularly with Novo Nordisk, Novozymes, and Biomodics. She has secured substantial research funding totaling approximately 650,000 EUR annually, including major grants from the Danish Research Foundation, Innovation Fund Denmark, Novo Nordisk Foundation, and Lundbeck Foundation. As an educator, Arleth has supervised 14 PhD students (11 graduated) and 18 postdoctoral researchers, while teaching at all academic levels. Her administrative leadership includes serving on the NBI Research Council and Research Funding Committee since 2019, and previously leading large academic units serving over 700 PhD and 750 physics students.

• Endocrinology
• Diabetes
• Metabolism
• +۵ مورد دیگر

Steen Bendix Haugaard is a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His primary clinical specialization is in Internal Medicine with a focus on Endocrinology. Based at Bispebjerg Hospital (Bispebjerg Bakke 23, 2400 København NV) and the main university hospital campus (Blegdamsvej 3, 2200 København N), he maintains an active research and clinical practice in endocrinology and diabetes care. Dr. Haugaard's research focuses on several key areas within endocrinology and metabolism. His primary interests include: Diabetes pathophysiology and management Glucagon signaling and resistance Lipoprotein metabolism in metabolic disorders FGF21 and GDF15 as metabolic biomarkers Blood pressure variability and cardiovascular risk Metabolic Associated Steatotic Liver Disease (MASLD) His recent publication record demonstrates a strong focus on clinical endocrinology research, with numerous high-impact publications in leading journals including Diabetes Care, Diabetes, American Journal of Clinical Nutrition, and Journal of the Endocrine Society. His work often involves large-scale clinical studies and randomized controlled trials examining metabolic parameters in diabetes and obesity. A significant portion of his recent work investigates the role of glucagon in metabolic regulation and the development of novel diagnostic tools like the GLUSENTIC test for assessing glucagon resistance. Dr. Haugaard has received attention for his research, with several publications picked up by news outlets, blogged about, and shared across social media platforms including X (Twitter), Facebook, and Reddit. His work has garnered substantial academic interest with numerous readers on Mendeley.

Carrie Wieseمشاهده پروفایل

استادیار

• Cardiometabolic physiology
• Sex differences in disease
• Genetic sex impact on physiology
• +۴ مورد دیگر

Dr. Carrie Wiese is an Assistant Professor in the Department of Pharmacology at the LSU Health Sciences Center School of Medicine in New Orleans, Louisiana. Her research focuses on the impact of sex components—gonads and sex chromosomes—on cardiometabolic physiology, with particular emphasis on how genetic sex influences disease mechanisms. Education: Postdoctoral Fellowship in Human Genetics, University of California, Los Angeles (2024) Ph.D. in Molecular Physiology & Biophysics, Vanderbilt University (2019) B.S. in Molecular Biology, University of Tennessee, Chattanooga (2008) Dr. Wiese's research investigates how the sex chromosome complement (XX and XY) causes unequal gene dosage through two mechanisms: 1) the presence and absence of Y chromosome genes and 2) a subset of X chromosome genes escaping X chromosome inactivation, leading to higher expression in XX cells than XY cells. These mechanisms modulate cellular function and impact whole-body physiology. Her current research projects include utilizing multi-omics approaches to assess the impact of gonadal and genetic sex on hepatic function during fatty liver disease, evaluating the impact of sex on epigenetic regulation in atherosclerosis, and determining the role of X chromosome gene Kdm6a in brown adipose energy metabolism. Dr. Wiese has published extensively on sex differences in cardiometabolic disease, with recent publications focusing on X chromosome dosage effects, sex differences in lipid metabolism, and the role of specific genes in sex-biased disease phenotypes. Her work bridges basic genetic mechanisms with clinical implications for understanding sex differences in disease susceptibility and treatment response. Scientific Awards: No specific awards mentioned in the provided text Dr. Wiese is actively mentoring graduate students and post-doctoral fellows in her laboratory. Her research has significant implications for understanding sex differences in disease mechanisms and developing more personalized approaches to treating cardiometabolic disorders. She is currently accepting new graduate students and post-doctoral fellows to join her research team. Dr. Wiese's laboratory is part of the Cardiovascular Center at LSU Health Sciences Center, where she collaborates with other researchers investigating cardiovascular disease mechanisms and potential therapeutic approaches.

• Population Genomics
• Evolutionary Bioinformatics
• Microbial Evolution
• +۳ مورد دیگر

Weigang Qiu is a Professor in the Department of Biological Sciences at Hunter College, part of the City University of New York (CUNY). His research focuses on the population genomics of microbial pathogens, particularly the Lyme disease bacterium Borrelia burgdorferi . Dr. Qiu received his educational training from: BS in Biochemistry from Fudan University, China (1986) PhD in Ecology and Evolution from State University of New York at Stony Brook (1999) Postdoctoral training in Bioinformatics at University of Maryland Biotechnology Institute (2002) Dr. Qiu's research interests center on evolutionary bioinformatics and pathogen variability. His lab specializes in comparative analysis of multiple genomes of the Lyme disease pathogen, reconstructing the history of worldwide diversification of Lyme disease bacteria, understanding mechanisms of genome evolution (particularly roles of recombination and natural selection), and inference of gene and genome functions. His approach is primarily bioinformatics-based, focusing on computational and statistical testing of evolutionary hypotheses. Students in his lab learn modern computational tools including relational databases/SQL, Perl/BioPerl, and statistical computing with R. Analysis of Dr. Qiu's publication record shows a consistent focus on Lyme disease pathogens and bacterial evolution, with recent work expanding into cancer biology and thyroid cancer research. His research demonstrates interdisciplinary connections between evolutionary biology, microbiology, and medical applications, highlighting how evolutionary principles can inform our understanding of disease mechanisms. Dr. Qiu teaches several courses including Molecular Evolution (BIOL 375), Computational Molecular Biology (BIOL 425), Bioinformatics Summer Workshop (BIOL 470), and Microbiology (BIOL 230). He is also involved in the QuBi Project for curricular improvement in quantitative biology. Dr. Qiu leads the Qiu Lab, which focuses on bioinformatics tools development for bacterial genomics research. The lab has developed several specialized tools including: Borrelia Ortholog Retriever: For obtaining ortholog alignments from 23 Borrelia spp genomes SimBac: A package for simulating bacterial genome evolution DNATweezer: A Perl wrapper of BioPerl modules The Bio::Align::Graphics module

Holger Gerhardtمشاهده پروفایل

استاد

• angiogenesis
• tumour angiogenesis
• vascular plasticity
• +۷ مورد دیگر

Professor Holger Gerhardt is DZHK Professor for Experimental Cardiovascular Research at the Charité - Universitätsmedizin Berlin and Head of the Integrative Vascular Biology Laboratory at Max-Delbrück Center for Molecular Medicine in Berlin-Buch. He also serves as Vice-spokesperson of the DZHK Partnersite Berlin, Speaker of the DZHK Professors, and holds a Professorship at the Berlin Institute of Health. Additionally, he is the European coordinator for the Fondation Leducq transatlantic network of excellence ATTRACT and a member of the DZHK Board of Directors since July 2024. Professor Gerhardt's research focuses on unraveling the fundamental principles and molecular/genetic regulation of functional vascular network formation in development and disease. His work aims to advance understanding of mechanisms controlling the formation and patterning of vascular networks to inform therapeutic approaches for cardiovascular complications and tissue homeostasis restoration. He has made key discoveries including the mechanism of vascular lumen formation by inverse membrane blebbing under blood pressure, the identification of a phase transition in Notch signaling dynamics that switch blood vessel formation from branching to expansion, a role for YAP/TAZ signaling in controlling junctional dynamics and plasticity, and a role of primary cilia in endothelial cells sensitizing nascent vessels to the stabilizing activity of BMP under blood flow. His publication record demonstrates a consistent focus on vascular biology, angiogenesis, and cardiovascular research, with recent work expanding into areas such as bone healing, renal fibrosis, and immune-metabolic crosstalk in cardiovascular disease. His research combines advanced imaging techniques, genetic manipulation, and computational modeling to address fundamental questions in vascular development and disease. Chair Gordon Research Conference Angiogenesis (2015) Hooke Medal of the British Society for Cell Biology (2012) Judah Folkman Award of the North American Vascular Biology Organization (2011) Walter Flemming Medal of the German Society for Cell Biology (2009) Lister Institute of Preventive Medicine Prize (2008) Professor Gerhardt actively mentors PhD students and leads a research team at the Max-Delbrück Center. His laboratory receives funding from various sources including the German Center for Cardiovascular Research (DZHK) and the Fondation Leducq. He collaborates extensively with researchers across Europe and internationally, particularly through the ATTRACT network. The Integrative Vascular Biology Laboratory maintains state-of-the-art facilities for in vivo imaging, genetic manipulation, and computational modeling. The lab is part of the vibrant research community at the Max-Delbrück Center and collaborates closely with clinicians at the Charité hospital to translate basic research findings into potential clinical applications.

Kevin Huynhمشاهده پروفایل

پژوهشگر ارشد

• Lipidomics
• Mass spectrometry
• Lipid Metabolism
• +۴ مورد دیگر

Dr. Kevin Huynh is a Research Fellow and Group Leader at the Baker Heart and Diabetes Institute, holding an NHMRC Emerging Leadership Fellowship. He maintains academic appointments at both La Trobe University within the Baker Department of Cardiovascular Research, Translation and Implementation and at the University of Melbourne within the Baker Department of Cardiometabolic Health. Dr. Huynh's educational background includes: Bachelor of Science in Human Pathology from the University of Melbourne Honours year completed in 2011 at the University of Melbourne examining secretases in Alzheimer's disease PhD completed in 2019 from Monash University under Professor Peter Meikle and Associate Professor Brian Drew Dr. Huynh's research focuses on developing mass spectrometry techniques for lipid analysis, with particular emphasis on understanding lipid metabolism in neurodegenerative and metabolic diseases. His laboratory has established a comprehensive lipidomics platform that enables high-throughput profiling of lipid metabolites in human plasma. This platform has been instrumental in characterizing lipid signatures associated with Alzheimer's disease, type 2 diabetes, and cardiovascular conditions. His recent publications demonstrate a strong trend toward understanding the relationship between lipid metabolism and disease mechanisms through large cohort studies and multi-omics integration. His work increasingly incorporates machine learning approaches to analyze complex lipidomic datasets and identify biomarkers for early disease detection and risk stratification. Dr. Huynh's scientific achievements include: NHMRC EL1 Investigator grant (2021–2025) for research on lipid metabolism in Alzheimer's disease ARC Discovery Project grant as Chief Investigator A (2023–2025) for novel lipidomic analysis methods Sir Laurence Muir Prize from Baker Institute (2021) John Funder Award for Best Early Career Scientist presentation (2021) Multiple invitations to present at international conferences including the Metabolomics Society and ASMS As a Group Leader, Dr. Huynh oversees a research program that has secured significant funding and established collaborations across multiple institutions. His NHMRC fellowship supports his investigation into lipid metabolism in Alzheimer's disease using peripheral immune cells, while his ARC Discovery Project focuses on developing high-throughput lipidomic analysis approaches. Dr. Huynh leads the Metabolomics Laboratory at the Baker Heart and Diabetes Institute, where his team specializes in mass spectrometry-based lipid analysis. The laboratory has developed advanced methodologies for high-throughput lipid profiling and has contributed significantly to understanding the lipid signatures associated with various diseases, with strong connections to clinical researchers for translational applications.